Advertisement

Pediatric Nephrology

, Volume 29, Issue 1, pp 95–102 | Cite as

Subclinical cardiovascular disease and its association with risk factors in children with steroid-resistant nephrotic syndrome

  • Cengiz Candan
  • Nur Canpolat
  • Selman Gökalp
  • Nurdan Yıldız
  • Pınar Turhan
  • Mehmet Taşdemir
  • Lale Sever
  • Salim Çalışkan
Original Article

Abstract

Background

The aim of this study was to evaluate the presence of subclinical cardiovascular disease (CVD) and its relation to risk factors in pediatric patients with steroid-resistant nephrotic syndrome (NS).

Methods

Thirty-seven patients with normal renal function were compared with 22 healthy controls regarding the presence of subclinical CVD. Measurements included aortic pulse wave velocity (PWV), carotid intima media thickness (IMT), and left ventricular mass (LVM). Patients were additionally assessed for blood pressure (BP) pattern and the presence of hypertension by 24-h ambulatory blood pressure monitoring.

Results

Compared with the controls, patients had significantly higher mean aortic PWV-standard deviation scores (SDS), mean carotid IMT-SDS, and LVM index (p < 0.001 for all). Increased aortic PWV was noted in 5 % of patients, increased carotid IMT in 22 %, and increased LVM index in 19 %. Five patients (14 %) were hypertensive, and mean BP indexes, SDS, and BP loads during nighttime were significantly higher than those during daytime (p < 0.001 for all). Multivariate analysis revealed a significant relationship between PWV-SDS and ferritin (R 2 = 0.269, p = 0.006) and between carotid IMT-SDS and proteinuria (R 2 = 0.141, p = 0.022). The LVM index was independently associated only with higher body mass index SDS (R 2 = 0.317, p < 0.001). In addition, six patients (16 %) had multiple abnormal subclinical CVD markers, and increased subclinical CVD risk was independently associated only with higher low-density lipoprotein cholesterol (R 2 = 0.292, p = 0.044).

Conclusions

Based on these results, steroid-resistant NS children generally are at high risk of cardiovascular complications, but the increased risk is likely to be multifactorial.

Keywords

Steroid-resistant nephrotic syndrome Aortic stiffness Atherosclerosis Cardiovascular disease Childhood 

Notes

Disclosure

None

References

  1. 1.
    Ordonez JD, Hiatt RA, Killebrew EJ, Fireman BH (1992) The increased risk of coronary heart disease associated with the nephrotic syndrome. Kidney Int 44:638–642CrossRefGoogle Scholar
  2. 2.
    Adedoyin O, Frank R, Vento S, Vergara M, Gauthier B, Trachtman H (2004) Cardiac disease in children with primary glomerular disorders role of focal segmental glomerulosclerosis. Pediatr Nephrol 19:408–412PubMedCrossRefGoogle Scholar
  3. 3.
    Lechner BL, Bockenhauer D, Iragorri S, Kennedy TL, Siegel NJ (2004) The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome. Pediatr Nephrol 19:744–748PubMedCrossRefGoogle Scholar
  4. 4.
    Kniażewska MH, Obuchowicz AK, Wielkoszyński T, Żmudzińska-Kitczak J, Urban K, Marek M, Witanowska J, Sieroń-Stołtny K (2009) Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome. Pediatr Nephrol 24:549–554PubMedCrossRefGoogle Scholar
  5. 5.
    Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629–639PubMedCrossRefGoogle Scholar
  6. 6.
    Querfeld U (1999) Should hyperlipidemia in children with nephrotic syndrome be treated? Pediatr Nephrol 13:77–84PubMedCrossRefGoogle Scholar
  7. 7.
    Chan DT, Irish AB, Dogra GK, Watts GF (2008) Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials. Atherosclerosis 196:823–834PubMedCrossRefGoogle Scholar
  8. 8.
    Litwin M, Niemirska A (2009) Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol 24:707–719PubMedCrossRefGoogle Scholar
  9. 9.
    Tomiyama H, Yamashina A (2010) Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J 74:24–33PubMedCrossRefGoogle Scholar
  10. 10.
    Schwartz GJ, Gauthier B (1985) A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106:522–526PubMedCrossRefGoogle Scholar
  11. 11.
    International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome for initial response to prednisone. J Pediatr 98:561–564CrossRefGoogle Scholar
  12. 12.
    Neyzi O, Furman A, Bundak R, Gunoz H, Darendeliler F, Bas F (2006) Growth references for Turkish children aged 6 to 18 years. Acta Pediatr 95:1635–1641CrossRefGoogle Scholar
  13. 13.
    Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O (2006) Body mass index references for Turkish children. Acta Pediatr 95:194–198CrossRefGoogle Scholar
  14. 14.
    Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y (1997) Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 20:1562–1568PubMedCrossRefGoogle Scholar
  15. 15.
    D’Annunzio G, Vanelli M, Pistorio A, Minuto N, Bergamino L, Iafusco D, Lorini R, the Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED) (2009) Insulin resistance and secretion indexes in healthy Italian children and adolescents: a multicenter study. Acta Biomed 80:21–28PubMedGoogle Scholar
  16. 16.
    Soergel M, Kirschstein M, Busch C, Danne T, Gellermann JJ, Holl R, Krull F, Reichert H, Reusz GS, Rascher W (1997) Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 130:178–184PubMedCrossRefGoogle Scholar
  17. 17.
    Wuhl E, Witte K, Soergel M, Mehls O, Schaefer F, Germany Working Group on Pediatric Hypertension (2002) Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007PubMedCrossRefGoogle Scholar
  18. 18.
    Kracht D, Shroff R, Baig S, Doyon A, Jacobi C, Zeller R, Querfeld U, Schaefer F, Wühl E, Schmidt BM, Melk A, 4C Study Consortium (2011) Validating a new oscillometric device for aortic pulse wave velocity measurements in children and adolescents. Am J Hypertens 24:1294–1299PubMedCrossRefGoogle Scholar
  19. 19.
    Reusz GS, Cseprekal O, Temmar M, Kis E, Cherif AB, Thaleb A, Fekete A, Szabó AJ, Benetos A, Salvi P (2010) Reference values of pulse wave velocity in healthy children and teenagers. Hypertension 56:217–224PubMedCrossRefGoogle Scholar
  20. 20.
    Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS, American Society of Echocardiography Carotid Intima-Media Thickness Task Force (2008) Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 21:93–111PubMedCrossRefGoogle Scholar
  21. 21.
    Jourdan C, Wühl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenk JP, Grenda R, Mehls O, Tröger J, Schaefer F (2005) Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 23:1707–1715PubMedCrossRefGoogle Scholar
  22. 22.
    Sahn DJ, De Maria A, Kisslo J, Weyman A (1978) Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1083PubMedCrossRefGoogle Scholar
  23. 23.
    Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 55:613–618PubMedCrossRefGoogle Scholar
  24. 24.
    De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Diviitis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260PubMedCrossRefGoogle Scholar
  25. 25.
    Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22:709–714PubMedCrossRefGoogle Scholar
  26. 26.
    Khosdel AR, Carney SL, Nair BR, Gillies A (2007) Better management of cardiovascular diseases by pulse wave velocity: combining clinical practice with clinical research using evidenced based medicine. Clin Med Res 5:45–52CrossRefGoogle Scholar
  27. 27.
    Dogra GK, Watts GF, Herrmann S, Thomas MAB, Irish AB (2002) Statin therapy improves brachial artery endothelial function in nephrotic syndrome. Kidney Int 62:550–557PubMedCrossRefGoogle Scholar
  28. 28.
    Tkaczyk M, Czupryniak A, Owczarek D, Lukamowicz J, Nowicki M (2008) Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome. Am J Nephrol 28:197–202PubMedCrossRefGoogle Scholar
  29. 29.
    Agarwal R (2008) Iron, oxidative stress, and clinical outcomes. Pediatr Nephrol 23:1195–1199PubMedCrossRefGoogle Scholar
  30. 30.
    Kamireddy R, Kavuri S, Devi S, Vemula H, Chandana D, Harinarayanan S, James R, Rao A (2002) Oxidative stress in pediatric nephrotic syndrome. Clin Chim Acta 325:147–150PubMedCrossRefGoogle Scholar
  31. 31.
    Mishra OP, Gupta AK, Prasad R, Ali Z, Upadhyay RS, Mishra SP, Tiwary NK, Schaefer FS (2011) Antioxidant status of children with idiopathic nephrotic syndrome. Pediatr Nephrol 26:251–256PubMedCrossRefGoogle Scholar
  32. 32.
    Wasilewska A, Zoch-Zwierz W, Tobolczyk J, Tenderenda E (2007) High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome. Pediatr Nephrol 22:403–408PubMedCrossRefGoogle Scholar
  33. 33.
    Kuo HT, Kuo MC, Chiu YW, Chang YW, Guh JY, Chen HC (2005) Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis. Eur J Clin Invest 35:245–250PubMedCrossRefGoogle Scholar
  34. 34.
    Bakr A, Hassan SA, Shoker M, Zaki M, Hassan R (2009) Oxidant stress in primary nephrotic syndrome: does it modulate the response to corticosteroids? Pediatr Nephrol 24:2375–2380PubMedCrossRefGoogle Scholar
  35. 35.
    Jin J, Jin B, Huang S, Yuan Y, Ding D, Bao H, Chen Y, Han Y, Zhao F, Zhang A (2012) Insulin resistance in children with primary nephrotic syndrome and normal renal function. Pediatr Nephrol 27:1901–1909PubMedCrossRefGoogle Scholar
  36. 36.
    Dogra GK, Herrmann S, Irish AB, Thomas MAB, Watts GF (2002) Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome. Nephrol Dial Transplant 17:2220–2225PubMedCrossRefGoogle Scholar
  37. 37.
    Zilleruelo G, Hsia SL, Freundlich M, Gorman HM, Strauss J (1984) Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome. J Pediatr 104:61–64PubMedCrossRefGoogle Scholar
  38. 38.
    Grimm RH, Svendsen KH, Kasiske B, Keane WF, Wahi MM (1997) Proteinuria is a risk factor for mortality over 10 years of follow-up: MRFIT Research Group, Multiple Risk Factor Intervention Trial. Kidney Int 63:S10–S14Google Scholar
  39. 39.
    Książek J, Niemirska A, Lipka M, Grenda R (2006) Evaluation of arterial intima-media thickness (IMT) in children with idiopathic nephrotic syndrome—preliminary report. Przegl Lek 63[Suppl 3]:205–207PubMedGoogle Scholar
  40. 40.
    Ohkubo T, HozawaA YJ, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y (2002) Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 20:2183–2189PubMedCrossRefGoogle Scholar
  41. 41.
    Routledge FS, McFetridge-Durdle JA, Dean CR, Canadian Hypertension Society (2007) Night-time blood pressure patterns and target organ damage: a review. Can J Cardiol 23:132–138PubMedCrossRefGoogle Scholar
  42. 42.
    Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B, CiKD Study Group (2010) Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 21:137–144PubMedCrossRefGoogle Scholar
  43. 43.
    Nakamura A, Niimi R, Kurosaki K, Yanagawa Y (2010) Factors influencing cardiovascular risk following termination of glucocorticoid therapy for nephrotic syndrome. Clin Exp Nephrol 14:457–462PubMedCrossRefGoogle Scholar
  44. 44.
    Fardet L (2013) Metabolic and cardiovascular adverse events of systemic glucocorticoid therapy. Rev Med Interne 34:303–309PubMedCrossRefGoogle Scholar
  45. 45.
    Foster BJ, Shults J, Zemel BS, Leonard MB (2006) Risk factors for glucocorticoid-induced obesity in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 21:973–980Google Scholar
  46. 46.
    Wisniewski AB, Chernausek SD (2009) Gender in childhood obesity: family environment, hormones, and genes. Gend Med 6[Suppl 1]:76–85PubMedCrossRefGoogle Scholar
  47. 47.
    Frishberg Y, Feinstein S, Rinat C, Becker-Cohen R, Lerer I, Raas-Rothschild A, Ferber B, Nir A (2006) The heart of children with steroid-resistant nephrotic syndrome: is it all podocin? J Am Soc Nephrol 17:227–231PubMedCrossRefGoogle Scholar
  48. 48.
    Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, Didonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL (2013) Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19:576–585PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2013

Authors and Affiliations

  • Cengiz Candan
    • 1
  • Nur Canpolat
    • 2
  • Selman Gökalp
    • 3
  • Nurdan Yıldız
    • 1
  • Pınar Turhan
    • 1
  • Mehmet Taşdemir
    • 2
  • Lale Sever
    • 2
  • Salim Çalışkan
    • 2
  1. 1.Division of Pediatric NephrologyIstanbul Medeniyet University and Göztepe Training and Research HospitalIstanbulTurkey
  2. 2.Department of Pediatric Nephrology, Cerrahpaşa Faculty of MedicineIstanbul UniversityIstanbulTurkey
  3. 3.Department of Pediatric Cardiology, Cerrahpaşa Faculty of MedicineIstanbul UniversityIstanbulTurkey

Personalised recommendations